Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Johnatty, Sharon E.
Beesley, Jonathan
Chen, Xiaoqing
Macgregor, Stuart
Duffy, David L.
Spurdle, Amanda B.
deFazio, Anna
Gava, Natalie
Webb, Penelope M.
Rossing, Mary Anne
Doherty, Jennifer Anne
Goodman, Marc T.
Lurie, Galina
Thompson, Pamela J.
Wilkens, Lynne R.
Ness, Roberta B.
Moysich, Kirsten B.
Chang-Claude, Jenny
Wang-Gohrke, Shan
Cramer, Daniel W.
Terry, Kathryn L.
Hankinson, Susan E.
Tworoger, Shelley S.
Garcia-Closas, Montserrat
Yang, Hannah
Lissowska, Jolanta
Chanock, Stephen J.
Pharoah, Paul D.
Song, Honglin
Whitemore, Alice S.
Pearce, Celeste L.
Stram, Daniel O.
Wu, Anna H.
Pike, Malcolm C.
Gayther, Simon A.
Ramus, Susan J.
Menon, Usha
Gentry-Maharaj, Aleksandra
Anton-Culver, Hoda
Ziogas, Argyrios
Hogdall, Estrid
Kjaer, Susanne K.
Hogdall, Claus
Berchuck, Andrew
Schildkraut, Joellen M.
Iversen, Edwin S.
Moorman, Patricia G.
Phelan, Catherine M.
Sellers, Thomas A.
Cunningham, Julie M.
Vierkant, Robert A.
Rider, David N.
Goode, Ellen L.
Haviv, Izhak
Chenevix-Trench, Georgia
and
Dermitzakis, Emmanouil T.
2010.
Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer Susceptibility “Hot-Spot”.
PLoS Genetics,
Vol. 6,
Issue. 7,
p.
e1001016.
Braem, M.G.M.
Schouten, L.J.
Peeters, P.H.M.
den Brandt, P.A. van
and
Onland-Moret, N.C.
2011.
Genetic susceptibility to sporadic ovarian cancer: A systematic review.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,
Vol. 1816,
Issue. 2,
p.
132.
Meng, Qing H
Xu, Enping
Hildebrandt, Michelle A T
Liang, Dong
Lu, Karen
Ye, Yuanqing
Wagar, Elizabeth A
and
Wu, Xifeng
2014.
Genetic Variants in the Fibroblast Growth Factor Pathway as Potential Markers of Ovarian Cancer Risk, Therapeutic Response, and Clinical Outcome.
Clinical Chemistry,
Vol. 60,
Issue. 1,
p.
222.
Jiang, Guangyuan
Xiao, Gang
Luo, Chao
Tang, Zhaohua
Teng, Zhipeng
and
Peng, Xing
2021.
Correlation Between SNPs at the 3'UTR of the FGF2 Gene and Their Interaction with Environmental Factors in Han Chinese Diabetic Peripheral Neuropathy Patients.
Journal of Molecular Neuroscience,
Vol. 71,
Issue. 2,
p.
203.
Gaibar, María
Galán, Miguel
Romero-Lorca, Alicia
Antón, Beatriz
Malón, Diego
Moreno, Amalia
Fernández-Santander, Ana
and
Novillo, Apolonia
2021.
Genetic Variants of ANGPT1, CD39, FGF2 and MMP9 Linked to Clinical Outcome of Bevacizumab Plus Chemotherapy for Metastatic Colorectal Cancer.
International Journal of Molecular Sciences,
Vol. 22,
Issue. 3,
p.
1381.
Hong, Hi-Ju
Shao, Yanfei
Zhang, Sen
Yang, Guang
Jia, Hongtao
Yang, Xiao
Huang, Ling
Li, Shuchun
Aikemu, Batuer
Zhang, Luyang
Ma, Junjun
Zang, Lu
Sun, Jing
and
Zheng, Minhua
2022.
ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy inmetastatic colorectal cancer.
Acta Biochimica et Biophysica Sinica,
Vol. 54,
Issue. 11,
p.
1671.
Chen, Sihan
Li, Zhangyun
Wang, Yanyan
and
Fan, Shaohua
2022.
BTN3A3 inhibits the proliferation, migration and invasion of ovarian cancer cells by regulating ERK1/2 phosphorylation.
Frontiers in Oncology,
Vol. 12,
Issue. ,